FDA Pre-NDA Meeting Outcomes - TLX591-CDx illumet
Filed with ASX · · 3 pages · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallTelix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Appendix 4D and Financial Report for half-year to 30 June 19
- First Australian Patient Dosed in ZIRCON Phase III Trial
- Telix Pharmaceuticals announces results of successful SPP
- Telix and GenesisCare Commence Prostate Cancer Study
- Telix and Merck Group Combination Therapy Collaboration
Later from Telix Pharmaceuticals
- Telix to Acquire European Production Facility
- Appendix 4C - September 2019 quarter
- Telix and AusHealth Partner for Lung, Ovarian Cancer
- Telix and ATONCO Partner for Bladder Cancer
- Telix and Vic Cancer Centre receive Cancer Australia grant
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals